Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

The Lancet
May 16, 2020 Volume 395 Number 10236 p1521-1586, e83-e89
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang, et al.